Ferras Zalt, a Director, acquired 580,000 Common Shares on a direct ownership basis at a price of $0.470 on November 14th, 2019. This represents a $272,600 investment into the company's shares and an account share holdings change of 23.3%.
Elixxer is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Elixxer Ltd, formerly LGC Capital Ltd, is a Canada-based cannabis investment company. The Company is focused on the legal global cannabis market. It is focused on cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy and Canada serving domestic and export markets. It sells cannabis products across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands, as well as medical cannabis oils in Australia under the Little Green Pharma brand. Its products are available in a range of formats, including dry cannabis flower, tinctures, oils, seeds, and beverages.
No Comments